Navigation Links
Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
Date:8/23/2007

Genetic Biomarker Portfolio to Have Important Role in Targeted Drug

Development, Dosing Determination, and Pharmacogenetic Testing

Purchase Expands European Presence, Advances PGxHealth Test

Commercialization and Broadens Geographic Reach of Cogenics'

Pharmacogenomics Services

NEWTON, Mass., Aug. 23 /PRNewswire-FirstCall/ -- Clinical Data, Inc. (Nasdaq: CLDA) announced today that it has acquired privately held Epidauros Biotechnologie AG of Bernried, Germany, in a cash transaction valued at 8.75 million euros (or approximately $11.84 million). Epidauros brings to Clinical Data an established portfolio of proprietary genetic biomarkers, expertise in genetic biomarker discovery, relationships with leading diagnostic companies, and a fast-growing pharmacogenomics services business.

Among the strategic assets acquired by Clinical Data in the transaction is a significant intellectual property portfolio that includes biomarkers in genes relating to prominent drug transporters such as MDR1(1), OCT1(2), MRP1(3), and important cytochrome P450 drug metabolizing genes, such as CYP2B6(4) and CYP2D6(5). MDR1 encodes P-glycoprotein, a key protein involved in drug transport that is known to modulate drug disposition. In addition, the genes CYP2B6, OCT1, and MRP1 are implicated in the absorption, distribution, and metabolism of many drugs that span a variety of therapeutic classes and indications, and are likely to be important in both response and safety profiles for these drugs.

Clinical Data's President and CEO, Drew Fromkin, said, "We are pleased to have completed this highly strategic transaction, which we believe will enhance Clinical Data's ability to b
'/>"/>

SOURCE Clinical Data, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. BioRobot MDx standardize your automated protocols in clinical laboratories
2. What patients want: A story of choice, clinical trials & evidence-based medicine
3. ZyStor seeks to raise $15M for clinical trials
4. Prodesse begins clinical trials for flu virus detection
5. ConjuGon raises $3.3 million to fund clinical trials
6. Cancer-fighting agent heads for clinical trials
7. Quintessence cancer treatment chosen for clinical studies
8. Third Wave reports clinical growth, continued loss
9. Childrens expanding use of Sunrise Clinical Manager
10. Life-sciences conference to feature novel research with clinical potential
11. $14 million grant to drive clinical research at UW

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...,, HAYWARD, Calif., Nov. 6 Inta...s today on its ITCA 650 (DUROS® continuous de...type 2 diabetes at the Ninth Annual Diabetes Techn...http://www.newscom.com/cgi-bin/prnh/20050301/SFTU1...of Exenatide Via ITCA 650 Lowers Plasma Glucose, H...
(Date:11/5/2009)... , TRANSPORTATION -- Gone hybrid . . . , Fue...mobiles are now posted at the www.fueleconomy.gov...veloped and maintains for the U.S. Department of E.... Nine of the top 10 vehicles on the best fuel eco...Prius (51 MPG city; 48 highway). "This list proves...
(Date:11/5/2009)...,, WELLINGTON, Colo., Nov. 5 Th...dog towns in the western U.S. This rare carnivore...y susceptible to plague and often entire populatio...ldlife Service (FWS) has implemented a ferret bree...ve ferrets into their formerly native habitat. Un...
(Date:11/5/2009)...,, SAN DIEGO, Nov. 5 ...nced today that William Spencer, President and CEO...tory at the 2nd annual LD MICRO Conference on Thur...nset in Los Angeles. ,, About LD MICRO ,, LD...t focuses on finding undervalued companies in the ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
... in stem-cell research is strong, there are pitfal...hes to hold its leading position, according to UW-... . , ,Cezar, who recently joined UW to assist with... sponsored by the Wisconsin Innovation Network, a ...t the current state of stem-cell technology and wh...
...or incubator space for early-stage technology comp...MGE Innovation Center in University Research Park...suites ranging from about 700 square feet to nearl...of the Innovation Center, 510 Charmany Drive, in s...ems to its new headquarters in Verona. Constructio...
...siness venture of Mike Strand in Eau Claire and a ...n competition, has landed $250,000 from the Chipp...on, formerly Online Kiosks, has a plan to put vide...ple wait for appointments. After reaching the stat... emerging growth category at Eau Claire Area Econo...
Other Biology Technology:Competition for stem cell research is fierce 2Competition for stem cell research is fierce 3University Research Park to add 20 incubator suites 2
(Date:11/4/2009)... -- GenVault Corporation, the leader in ambient te...ry, medicine and identification, today announced t...CEO, will be presenting at the BIOCOM Investor Con...a Jolla, CA. ,, During the presentation, Dr. We...her with recent customer, technical and strategic ...
(Date:11/4/2009)...-- GenVault Corporation (Carlsbad, CA) today annou...ts Board of Directors. Dr. Brody, the Irwin Jacob...acclaimed physician-scientist and university leade... served as president of The Johns Hopkins Universi...ineering and the Institute of Medicine, and is ren...
(Date:11/3/2009)...of the ocean, cruising thousands of miles in a sol...ed that the sharks have maintained such a consiste...s of years the white sharks in the northeastern Pa...ation genetically distinct from sharks elsewhere i... mobile species," said Salvador Jorgensen, a postd...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Reliv International Launches New Products and Business Tools at 21st International Conference 54781 1Reliv International Launches New Products and Business Tools at 21st International Conference 54781 2Reliv International Launches New Products and Business Tools at 21st International Conference 54781 3Update 3A Medicare Picks N J to Test Innovative Incentive System 54779 1Update 3A Medicare Picks N J to Test Innovative Incentive System 54779 2Expresso Fitness 28R 29 Announces 246M Series D Funding 54777 1Expresso Fitness 28R 29 Announces 246M Series D Funding 54777 2Expresso Fitness 28R 29 Announces 246M Series D Funding 54777 3
... catching an infectious disease, according to new ...ich reveals airborne viruses can spread far and wi...International Laboratory for Air Quality and Healt...emitted from humans only travel a metre in the air...tists have been studying the way droplets carring ...
...ffalo have identified specific genes that are most... a process called DNA promoter hypermethylation. ,...hat promote normal cell growth to produce proteins...l growth. Until now, data has been very limited re...on, especially for hypermethylation in breast canc...
... smoking restrictions in the workplace and at home...School of Public Health found that nonsmokers who ...ace smoking ban are over two and a half times more... smoking bans. The study surveyed 1,472 Chinese A... , The study confirms that household smoking rest...
Other Biology News:Spreading viruses as we breathe 2Effect on breast tumors of DNA alternations in 3 genes described 2Better health twice as likely for nonsmokers who live and work with smoking restrictions 2
...ed immunospot) Kit analyzes interferon gamma (IFN&...t forms at the site where secreted cytokine is bou...pe or automated ELISPOT reader) and then compared ...is allows the frequency of cells secreting the cyt...
Corning Roller Bottle Easy Grip Caps, Sterile from Sigma-Aldrich
...ng Asuragens bioinformatics expertise. We offer th...data analysis using the most up to date methods. U...Expression Profiling Service or from your own micr...statistical analysis including publication quality...
CORNING 1700CM2 ROLLER BOTTLE, EASY GRIP CAP, GRADUATED, STERILE from Sigma-Aldrich
Biology Products: